EGFR and neoplasm: Supporting these data, our ex vivo slice cultures demonstrated increased tumor cell migration in EGFR-amplified tumors, and blockade of EGFR signaling with the small molecule inhibitor, gefitinib, induced a statistically significant reduction in migratory behavior within the same sample set11.